This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
CERA
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict SKIP-PERMANENT HIGH
Same class as EPO + darbepoetin. CERA was the doping vector in Tour de France 2008 (Schumacher, Kohl, Piepoli, Astana team) before WADA had a validated assay — that gap is now closed. For a tested combat athlete: SKIP-PERMANENT, same thrombosis risk as EPO at supraphysiologic hematocrit, longer washout makes it harder to clear from system before testing. No biohacking case.
▸ Verdict change log
- 2026-06-05 — Initial verdict SKIP-PERMANENT. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.